CD4+T cells in CIKs (CD4+ CIKs) reversed resistance to fas-mediated apoptosis through CD40/CD40L ligation rather than IFN-γ stimulation

Cancer Biotherapy and Radiopharmaceuticals

Volumn 23, Issue 3, 2008, Pages 342-354

  Yu, Jinpu ^a   Zhang, Weihong ^a   Jiang, Huawei ^a   Li, Hui ^a   Cao, Shui ^a   Ren, Xinbao ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

Author keywords

Apoptosis; Breast cancer; CD40 CD40L ligation; Fas dependent; IFN

Indexed keywords

ANTIBODY; BETA ACTIN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2; MONOCLONAL ANTIBODY; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BAX GENE; BCL 2 GENE; C FLIP GENE; CANCER PATIENT; CD4+ T LYMPHOCYTE; CYTOKINE INDUCED KILLER CELL; CYTOKINE RELEASE; EFFECTOR CELL; FADD GENE; FEMALE; FLOW CYTOMETRY; GENE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MALE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ANALYSIS; RAJI CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR; SUPERNATANT; UPREGULATION;

AGED; ANTIGENS, CD95; APOPTOSIS; BREAST NEOPLASMS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELL LINE, TUMOR; DRUG RESISTANCE; FEMALE; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; PROTEIN STRUCTURE, TERTIARY;

EID: 46449117297     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2007.0454     Document Type: Article

References (28)

1. Schmidt-Wolf GD, Negrin RS, Schmidt-Wolf IG. Activated T cells and cytokine-induced CD3+CD56+ killer cells. Ann Hematol 1997;74:51.
2. Margolin KA, Negrin RS, Wong KK, et al. Cellular immunotherapy and autologous transplantation for hematologic malignancy. Immunol Rev 1997;157:231.
3. Lu PH, Negrin RS. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol 1994;153:1687.
4. Ren X, Yu J, Liu H, et al. Th1 bias in PBMC induced by multicycles of auto-CIKs infusion in malignant solid tumor patients. Cancer Biother Radiopharm 2006;21:22.
5. Yu J, Ren X, Cao S, et al. Th1 polarization and apoptosis-inducing activity of CD4+ T -cells in cytokine-induced killers might favor the antitumor cytotoxicity of cytokine-induced killers in vivo. Cancer Biother Radiopharm 2006;21:276.
6. Briones J, Timmerman J, Levy R. In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma. Cancer Res 2002;62:3195.
7. Afford SC, Ahmed-Choudhury J, Randhawa S, et al. CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells. FASEB J 2001;15:2345.
8. Bernassola F, Scheuerpflug C, Herr I, et al. Induction of apoptosis by IFNgamma in human neuroblastoma cell lines through the FAS/FASL autocrine circuit. Cell Death Differ 1999;6:652.
9. Hougardy BM, van der Zee AG, van den Heuvel FA, et al. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid. Gynecol Oncol 2005;97:353.
10. Cohen GB, Kaur A, Johnson RP. Isolation of viable antigen-specific CD4 T cells by CD40L surface trapping. J Immunol Methods 2005;302:103.
11. Schmidt-Wolf IG, Lefterova P, Johnston V, et al. Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells. Cell Immunol 1996;169:85.
12. Hoyle C, Bangs CD, Chang P, et al. Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice. Blood 1998;92:3318.
13. Verneris MR, Kornacker M, Mailander V, et al. Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis. Cancer Immunol Immunother 2000;49:335.
14. Boehm U, Klamp T, Howard JC, et al. Cellular responses to interferon-gamma. Annu Rev Immunol 1997;15:749.
15. Takeda K, Hayakawa Y, Okumura K, et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 2001;7:94.
16. Hirano A, Longo DL, Taub DD, et al. Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand. Blood 1999;93:2999.
17. Grdisa M. Influence of CD40 ligation on survival and apoptosis of B-CLL cells in vitro. Leuk Res 2003;27:951.
18. Dallman C, Johnson PW, Packham G. Differential regulation of cell survival by CD40. Apoptosis 2003;8:45.
19. Lee, JK, Seki N, Sayers TJ, et al. Constitutive expression of functional CD40 on mouse renal cancer cells: induction of Fas and Fas-mediated killing by CD40L. Cell Immunol 2005;235:145.
20. Von Leoprechting A, Van der Breggen P, Pahl HL, et al. Stimulation of CD40 on immunogenic human malignant melanomas augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis. Cancer Res 1999,59:1287.
21. Hirano A, Longo DL, Taub DD, et al. Inhibition of human breast carcinoma growth b a soluble recombinant human CD40 ligand. Blood 1999;93:2999.
22. Tong AW, Papayoti Mh, Netto G, et al. Growth-inhibitory effects of CD40 ligand and its endogenous expression in human breast cancer. Clin Cancer Res 2001;7:691.
23. Toillon RA, Descamps S, Adriaenssens E, et al. Normal breast epithelial cells induce apoptosis of breast cancer cells via Fas signaling. Exp Cell Res 2002;275:31.
24. Yu W, Israel K, Liao QY, et al. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer Res 1999;59:953.
25. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the FAS (Fas/APO-1) death-inducing signaling complex. Cell 1996;85:817.
26. Krammer PH. FAS(APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol 1999;71:163.
27. Hacker G, Weber A. BH3-only proteins trigger cytochrome c release, but how? Arch Biochem Biophys 2007;462:150.
28. Tsujimoto Y. Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria? Genes Cells 1998;3:697.